Annual direct medical cost and contributing factors to total cost of epilepsy in Oman

Seizure

Volumn 12, Issue 8, 2003, Pages 555-560

  Al Zakwani, Ibrahim ^a,b,e   Hanssens, Yolande ^a   Deleu, Dirk ^c   Cohen, Abigail ^d   McGhan, William ^b   Al Balushi, Khalid ^c   Al Hashar, Amna ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c SULTAN QABOOS UNIVERSITY   (Oman)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e HEALTHCORE INC   (United States)

Author keywords

Antiepileptic drugs; Cost; Direct cost; Epilepsy; Oman

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; GABAPENTIN; LAMOTRIGINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; DRUG COST; ECONOMIC ASPECT; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITAL PHARMACY; HUMAN; INFORMATION RETRIEVAL; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NUCLEAR MAGNETIC RESONANCE IMAGING; OMAN; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RESOURCE ALLOCATION; UNIVERSITY HOSPITAL;

EID: 0344668629     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1059-1311(03)00068-2     Document Type: Article

References (16)

1. WHO Fact Sheet - Epilepsy: Epidemiology, Etiology and Prognosis [online]. Available from URL: http://www.who.int/inf-fs/en/fact165.html [accessed 12 February 2001].
2. Begley, C. E., Famulari, M., Annegers, J. F. et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia 2000; 41 (3): 342-351.
3. Annegers, J. F., Beghi, E. and Begley, C. E. Cost of epilepsy: contrast and methodologies in the United States and European Studies. Epilepsia 1999; 40 (Suppl. 8): 14-18.
4. Begley, C. E., Annegers, J. F., Lairson, D. R. et al. Estimating the cost of epilepsy. Epilepsia 1999; 40 (Suppl. 8): 8-13.
5. Heaney, D. C., Sander, J. W. A. S. and Shorvon, S. D. Comparing the cost of epilepsy across eight European countries. Epilepsy Research 2001; 43: 89-95.
6. Engel, J. Classifications of the International League Against Epilepsy: time for reappraisal. Epilepsia 1998; 39 (9): 1014-1017.
7. Joseph, F. H., Anderson, R. E., Tatham, R. L. and Black, W. C. Multivariate Data Analysis, 5th edn. Upper Saddle River, NJ, USA, Prentice Hall, 1998.
8. De Zelicourt, M., Buteau, L., Fagnani, F. et al. The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic seizures (the CAROLE study). Seizure 2000; 9: 88-95.
9. Halpern, M., Rentz, A. and Murray, M. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 2000; 19: 87-99.
10. Gnanamuthu, C., Paulose, G. and Meimmary, N. Epilepsy in Oman. A hospital-based 2-year survey in an adult epilepsy clinic. Oman Medical Journal 1994; 11: 10-13.
11. Hauser, W. A., Annegers, J. F. and Kurland, L. T. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34: 453-468.
12. Begley, C. E., Annegers, J. F., Lairson, D. R. et al. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 1994; 35: 1230-1243.
13. Cockerell, O. C., Hart, Y. M., Sander, J. W. A. S. and Shorvon, S. D. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Research 1994; 18: 249-260.
14. WHO. The World Health Report 2000 - Health Systems: Improving Performance. WHO, 2000: pp. 160-166.
15. Serrano, C. P. and Sanchez, A. J. Controversies about the new anti-epileptic drugs. Revista de Neurologia 2001; 32 (2): 165-171.
16. Cockerell, O. C. Pharmacoeconomic considerations in the drug treatment of epilepsy. CNS Drugs 1996; 6: 450-461.